This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Industry Symposia

ISA 2018 INDUSTRY SYMPOSIA

 

ISA 2018 has been working with industry leaders to provide our delegates with a selection of unique educational sessions. Meals will be provided as


part of the symposium. Please note that attendance at industry symposia do not offer continuing education credits unless otherwise noted. 

 

saturday JUNE 9

Symposium: A Hidden Cohort: What Could Be Hiding Behind a Diagnosis of Familial Hypercholesterolemia?
Time: 07:00 - 08:30 |  Room 714A

Understand the important role pediatric lipidologists play in diagnosing genetic diseases of lipid metabolism, recognize the importance of non-lipid biomarkers in differentiating lipid diseases and discuss recent advances in the identification and management of lysosomal acid lipase deficiency.

*Breakfast will be provided

 

 

SUNDAY JUNE 10

Symposium: Contemporary Issues in Cardiovascular Medicine
Time: 07:00 - 08:30 | Room 718

After taking part to this symposium, participants will be better able to:

  • Explain the pathophysiology of inflammation in the genesis of atherothrombosis
  • Summarize the results of the CANTOS trial of inflammation targeting in secondary prevention
  • Discuss the changing landscape of heart failure treatments in HFpEF and HFrEF
  • Evaluate the ongoing clinical trials in the area of heart failure

*Breakfast will be provided

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Symposium: Decoding Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome (FCS)
Time: 13:00 - 14:30 | Room 718

This symposium will focus on improving the differential diagnosis of Familial Chylomicronemia Syndrome (FCS) and referral of patients with FCS. A multidisciplinary, international panel of experts will guide the audience through the diagnostic process using patient case studies and clinical data. They will highlight the diverse manifestations of the disease, address key questions on diagnosis, present the diagnostic scoring systems being developed in Europe and North America and provide practical strategies for patient identification and referral. Throughout the program, the attendees will have the opportunity to provide their own opinions, ask critical questions and interact with the panel of experts.

*Lunch will be provided

 

MONDAY JUNE 11

Symposium: Omega-3, Triglycerides, and CVD: Current status and future directions
Time: 07:00 - 08:30 | Room 701

Attendees will:

  • Get a review and learn more about some of the MoAs of Omega-3 drugs
  • Get an overview and update of ongoing outcome trials on Omega-3 Rx drugs
  • Understand and appreciate the benefits of krill oils versus fish oil

*Breakfast will be provided 

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Symposium: Modern Management of Lipid-Related Cardiovascular Risk in Patients With Dyslipidemia
Time: 13:00 - 14:30 | Room 701

Attendees will:

  • Discuss the rationale for assessing and addressing cardiovascular risk early and effectively
  • Summarize recent clinical evidence on the safety and efficacy of comprehensive strategies to reduce lipid-related cardiovascular risk in patients with dyslipidemia
  • Evaluate safety and efficacy of lipid-lowering strategies that can be incorporated into clinical practice to improve cardiovascular outcomes

*Lunch will be provided

This CME activity is jointly provided by Oakstone Publishing, LLC and PeerVoice. This activity is supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -


Symposium: The PCSK9i Story: From Curiosity Science to Clinical Application 
Time: 13:00 - 14:30 | Room 718

Upon completion of this symposium, participants will be able to:

  • Understand the mechanism of PCSK9 as a novel LDL-C target
  • Critically appraise recent trials and outcome data for PCSK9 inhibitors
  • Evaluate PCSK9i therapeutic options, based on scientific and clinical evidence, to treat high risk patients across multiple patient populations

*Lunch will be provided

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -


 

Symposium: Bridging the Gaps in Treatment of Genetic Triglyceride Disorders: A Team-Based Approach to Differential Diagnoses and Management
Time: 13:00 - 14:30 | Room 801

Join our expert panel representing the healthcare team for this special session on effective diagnosis and optimal management of genetic dyslipidemias. Our panelists will simulate a clinic-like scenario and educate around three genetic triglyceride disorders. As a member of our audience, you will guess our patient's diagnosis and learn how to implement team-based care to create and maintain a comprehensive management plan. Grab lunch and engage in peer-to-peer decision making!

 

tuesday JUNE 12

Symposium: Optimizing statin therapy and reducing residual risk: From REAL-CAD to PROMINENT
Time: 13:00 - 14:30 | Room 718

*Lunch will be provided